BIO 2026: Rakuten Medical's drug-device 'photoimmunotherapy' is already approved in Japan for head & neck cancer - it is currently in a global phase 3 with an eye on a U.S. approval
- 2 hours ago
- 1 min read
COO Abhijit Bhatia describes how it works, and walks us through the design of the phase 3 and Rakuten Medical's global ambitions.
Coverage brought to you by











.png)